Routine cancer screenings look for cancer before a person exhibits any signs or symptoms. Treatment will most likely work best when cancer is caught early. Women may seek regular screenings for breast, cervical, and colorectal (colon) cancers. Walk-In Lab offers several cancer blood tests such as the Cancer Screening Panel, Women, the CA 15-3, and the CA 125. Thank you for browsing our selection of Cancer Screening blood tests and panels. Shop additional Women Specific Tests confidentially and order online without insurance or a doctor's note.
Choose One Lab: LABCORP (LC) or QUEST (QD) or ALL
Walk-In Lab is contracted with LabCorp (LC) and Quest Diagnostics (QD) for routine lab testing. Please choose LC or QD to complete your order. If you prefer to receive a kit by mail for specimen collection, please see our Home Test Kits. LC and QD tests must be ordered separately.
LabCorp: Online lab testing is prohibited in MA, MD, NY, NJ and RI.
Quest Diagnostics: Online lab testing is prohibited in AZ, NY, NJ and RI.
Cancer antigen 125 (CA-125) is a protein found in ovarian cancer cells. A CA-125 blood test measures the amount of cancer antigen 125 in the bloodstream. The protein is produced by the cells and can be found in the blood.
A Cancer Screening Panel for Women is a comprehensive screen for 5 cancer markers including Carcinoembryonic Antigen (CEA), Cancer Antigen 19-9, Cancer Antigen 125, Alpha-Fetoprotein (AFP) and Cancer Antigen 15-3 (CA 15-3).
This Cancer Antigen (CA) 15-3 Blood Test is used for monitoring the response to invasive breast cancer treatment and monitoring the recurrence of the disease.
The Cancer Antigen 27.29 blood test is used to monitor patients with breast cancer.
Useful in checking a female's ability to produce eggs that can be fertilized for pregnancy.
A Human Epididymis Protein 4 Blood Test is an aid in monitoring patients with treated epithelial ovarian cancer for recurrence or progression.
This Women's Health and Breast Profile, Saliva, measures hormone levels in the body to detect a hormone imbalance and assesses the risk of developing breast cancer or other hormone-sensitive cancers.